Records containing: Pemphigus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-20Comparison of a Personalized Maintenance Therapy Based on the Evolution of Anti-desmoglein Antibodies as Biomarkers of Pemphigus Subclinical Activity, With the Standard Treatment (Rituximab + Corticosteroids) in Pemphigus
-
CLINICAL_TRIALS study record update · 2026-02-12National Cohort for Evaluation of the Burden of Rare Skin Diseases
-
CLINICAL_TRIALS study record update · 2026-02-05Identification of Vulnerability Factors in the Course of Pemphigus Patients - SHS Pemphigus Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-01-07ONO-4059-10:Multicenter, Placebo-controlled, Randomized, Double-blind, Phase 3 Study in Patients With Steroid-resistant Pemphigus (BRILLIANT Study)
-
CLINICAL_TRIALS study record update · 2025-07-08The Use of IVIG in Combination With Rituximab VS Rituximab as the First Line Treatment of Pemphigus
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-04-01A Prospective, Single-Center, Single-Arm Clinical Study to Evaluate the Novel Humanized Cluster of Differentiation 38(CD38) Monoclonal Antibody (CM313) for the Treatment of Pemphigus
-
CLINICAL_TRIALS study record update · 2024-10-23Evaluation of Combination Therapy with Ofatumumab and Systemic Corticosteroids for Pemphigus: a Multi-center Cohort Study
-
CLINICAL_TRIALS study record update · 2024-10-10A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of B007 in Subjects With Pemphigus.
-
CLINICAL_TRIALS study record update · 2024-02-29Activation of Coagulation as an Indicator of a Pro-thrombotic State in Patients With Pemphigus: A Case-control Study
-
CLINICAL_TRIALS study record update · 2022-09-21A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Oral BTK Inhibitor Rilzabrutinib (PRN1008) in Moderate to Severe Pemphigus
-
CLINICAL_TRIALS study record update · 2022-09-19Validation of 5-Point Investigator Global Assessments for Pemphigus
-
CLINICAL_TRIALS study record update · 2022-03-17Increased Frequencies of Certain HLA Class II Alleles DRB1 and DQB1 in PV Patients Compared to Those in Healthy Donors Have Been Reported in Various Populations and Repeatedly Confirmed. Among the Russian Population, no Studies About the Association of PV and HLA Class II Genes Have Been Conducted. Thus, the Purpose of This Study Was to Investigate HLA Class II Alleles and Haplotypes in Russian Patients With Pemphigus Vulgaris.
-
CLINICAL_TRIALS study record update · 2020-02-05A Phase 1B/2, Multicenter, Open-Label, Safety, and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)
-
CLINICAL_TRIALS study record update · 2018-05-11Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid
-
CLINICAL_TRIALS study record update · 2017-06-14OPV117059: A Long-Term Extension Study of Ofatumumab Injection for Subcutaneous Use in Subjects With Pemphigus Vulgaris
-
CLINICAL_TRIALS study record update · 2016-12-22Combined Treatment of Autoimmune Bullous Diseases With Protein A Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab
-
CLINICAL_TRIALS study record update · 2016-03-25Evaluation of Sirolimus for the Treatment of the Autoimmune Blistering Dermatosis Pemphigus
-
CLINICAL_TRIALS study record update · 2015-02-19An Open Randomized Comparative Trial of Four Different Dressings for Cutaneous Coverage in Pemphigus and Pemphigoid
-
CLINICAL_TRIALS study record update · 2014-10-30A PILOT STUDY TO ASSESS THE EFFICACY OF RITUXIMAB VERSUS COMBINATION OF RITUXIMAB AND INTRAVENOUS CYCLOPHOSPHAMIDE IN THE TREATMENT OF REFRACTORY PEMPHIGUS
-
CLINICAL_TRIALS study record update · 2013-06-18Traitment of Patients Presenting Pemphigus With Anti CD20 (Mabthera).
-
CLINICAL_TRIALS study record update · 2013-04-08High Dose Cyclophosphamide & ATG With Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders: A Phase I Trial
-
CLINICAL_TRIALS study record update · 2013-01-31A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Infliximab in Subjects With Pemphigus Vulgaris Receiving Prednisone
-
CLINICAL_TRIALS study record update · 2012-10-23The RITAI Cohort. An Observational Study on Serious Adverse Events Occuring After Rituximab Off-label Use for Auto-immune Disorders
-
CLINICAL_TRIALS study record update · 2012-09-13EVALUATION CLINIQUE ET BIOLOGIQUE A LONG TERME DES PATIENTS ATTEINTS DE FORMES SEVERES DE PEMPHIGUS TRAITES PAR LE RITUXIMAB
-
CLINICAL_TRIALS study record update · 2011-05-02Treatment of Moderate to Severe Patients With Pemphigus With the Monoclonal Anti CD20 Antibody Rituximab at a Protocol of 1000mgX2 and Assessment of Their Immune Status Via the Cylex Test